Northwestern Mutual Investment Management Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.97M Sell
11,915
-107
-0.9% -$51.4K 0.07% 80
2026
Q1
$5.91M Buy
12,022
+17
+0.1% +$9.23K 0.09% 66
2025
Q4
$6.96M Sell
12,005
-30
-0.2% -$17K 0.08% 55
2025
Q3
$5.84M Sell
12,035
-8
-0.1% -$3.72K 0.08% 64
2025
Q2
$4.88M Sell
12,043
-123
-1% -$51.4K 0.08% 75
2025
Q1
$6.05M Buy
12,166
+22
+0.2% +$11.9K 0.1% 49
2024
Q4
$6.32M Buy
12,144
+37
+0.3% +$20.3K 0.14% 45
2024
Q3
$7.49M Sell
12,107
-40
-0.3% -$23.7K 0.17% 39
2024
Q2
$6.72M Sell
12,147
-113
-0.9% -$64.7K 0.17% 43
2024
Q1
$7.13M Buy
12,260
+31
+0.3% +$17.4K 0.19% 40
2023
Q4
$6.49M Buy
12,229
+47
+0.4% +$22.8K 0.17% 44
2023
Q3
$6.17M Buy
12,182
+15
+0.1% +$7.99K 0.17% 39
2023
Q2
$6.35M Sell
12,167
-161
-1% -$86.9K 0.17% 41
2023
Q1
$7.11M Buy
12,328
+35
+0.3% +$19.7K 0.18% 34
2022
Q4
$6.77M Sell
12,293
-2,259
-16% -$1.2M 0.18% 35
2022
Q3
$7.38M Sell
14,552
-2,796
-16% -$1.56M 0.18% 35
2022
Q2
$9.43M Sell
17,348
-88
-0.5% -$48.4K 0.21% 34
2022
Q1
$10.3M Sell
17,436
-2,078
-11% -$1.19M 0.23% 41
2021
Q4
$13M Sell
19,514
-202
-1% -$126K 0.25% 33
2021
Q3
$11.3M Buy
19,716
+1,867
+10% +$1.02M 0.23% 41
2021
Q2
$9M Sell
17,849
-3
-0% -$1.42K 0.16% 53
2021
Q1
$8.15M Sell
17,852
-3,898
-18% -$1.86M 0.14% 55
2020
Q4
$10.1M Buy
21,750
+53
+0.2% +$24.9K 0.13% 54
2020
Q3
$7.86M Hold
21,697
0.11% 58
2020
Q2
$7.86M Buy
21,697
+797
+4% +$267K 0.11% 56
2020
Q1
$5.93M Buy
20,900
+5,324
+34% +$1.68M 0.09% 80
2019
Q4
$5.06M Buy
15,576
+326
+2% +$98.8K 0.09% 80
2019
Q3
$4.44M Buy
15,250
+78
+0.5% +$22.3K 0.1% 82
2019
Q2
$4.46M Sell
15,172
-46,001
-75% -$12.7M 0.1% 80
2019
Q1
$16.7M Buy
61,173
+494
+0.8% +$123K 0.3% 76
2018
Q4
$13.6M Sell
60,679
-9,807
-14% -$2.3M 0.23% 78
2018
Q3
$17.2M Sell
70,486
-6,558
-9% -$1.51M 0.26% 85
2018
Q2
$16M Buy
77,044
+3,911
+5% +$830K 0.24% 76
2018
Q1
$15.1M Sell
73,133
-17,441
-19% -$3.66M 0.25% 76
2017
Q4
$17.2M Buy
90,574
+848
+0.9% +$162K 0.28% 76
2017
Q3
$17M Sell
89,726
-49
-0.1% -$8.87K 0.28% 72
2017
Q2
$15.7M Buy
89,775
+10,860
+14% +$1.82M 0.26% 76
2017
Q1
$12.1M Buy
78,915
+33,555
+74% +$5.13M 0.21% 86
2016
Q4
$6.4M Buy
45,360
+6,355
+16% +$937K 0.13% 92
2016
Q3
$6.2M Buy
39,005
+23,991
+160% +$3.7M 0.13% 77
2016
Q2
$2.22M Sell
15,014
-118
-0.8% -$17.4K 0.05% 156
2016
Q1
$2.14M Sell
15,132
-29
-0.2% -$3.89K 0.05% 168
2015
Q4
$2.15M Buy
15,161
+434
+3% +$57.9K 0.05% 208
2015
Q3
$1.8M Buy
14,727
+54
+0.4% +$7.04K 0.04% 237
2015
Q2
$1.9M Buy
14,673
+183
+1% +$23.9K 0.04% 257
2015
Q1
$1.95M Buy
+14,490
New +$1.87M 0.04% 259

Other funds holding TMO

Northwestern Mutual Investment Management Company's TMO Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company reduced its Thermo Fisher Scientific (TMO) stake by 0.89% in Q2 2026, selling an estimated $51.4K and leaving 11,915 shares worth $5.97M. The position accounts for 0.07% of the portfolio, ranked #80.

Northwestern Mutual Investment Management Company first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $17.2M in Q3 2018. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 11,915 shares of Thermo Fisher Scientific worth $5.97M as of Q2 2026.
  • Northwestern Mutual Investment Management Company sold 107 Thermo Fisher Scientific shares in Q2 2026, an estimated $51.4K.
  • Thermo Fisher Scientific made up 0.07% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #80 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
  • Northwestern Mutual Investment Management Company's Thermo Fisher Scientific position peaked at $17.2M in Q3 2018.
  • 2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.